NeuBase Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

COMMON STOCK WARRANTS (Tables)

COMMON STOCK WARRANTS (Tables)

6 Months Ended

Mar. 31, 2015

Below is a table summarizing the common stock warrants issued and outstanding as of March 31, 2015:

	Number Outstanding			Weighted-Average Exercise Price
Outstanding at September 30, 2014		1,947,008		$	3.64
Granted
Exercised		(436,366	)		2.55
Forfeited		(32,834	)		1.50
Outstanding at March 31, 2015		1,477,808		$	4.00

The outstanding warrants as of March 31, 2015 have an intrinsic value of $177,275.

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details